Previous Article | Next Article 
Journal of Virology, February 2000, p. 1168-1177, Vol. 74, No. 3
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Biochemical and Structural Analysis of Isolated
Mature Cores of Human Immunodeficiency Virus Type 1
Reinhold
Welker,
Heinrich
Hohenberg,
Uwe
Tessmer,
Carola
Huckhagel, and
Hans-Georg
Kräusslich*
Heinrich-Pette-Institut für
experimentelle Virologie und Immunologie an der Universität
Hamburg, D-20251 Hamburg, Germany
Received 3 August 1999/Accepted 4 November 1999
 |
ABSTRACT |
Mature human immunodeficiency virus type 1 (HIV-1) particles
contain a cone-shaped core structure consisting of the internal ribonucleoprotein complex encased in a proteinaceous shell derived from
the viral capsid protein. Because of their very low stability after
membrane removal, HIV-1 cores have not been purified in quantities
sufficient for structural and biochemical analysis. Based on our in
vitro assembly experiments, we have developed a novel method for
isolation of intact mature HIV-1 cores. Concentrated virus suspensions
were briefly treated with nonionic detergent and immediately
centrifuged in a microcentrifuge for short periods of time. The
resuspended pellet was subsequently analyzed by negative-stain and
thin-section electron microscopy and by immunoelectron microscopy. Abundant cone-shaped cores as well as tubular and aberrant structures were observed. Stereo images showed that core structures preserved their three-dimensional architecture and exhibited a regular
substructure. Detailed analysis of 155 cores revealed an average length
of ca. 103 nm, an average diameter at the base of ca. 52 nm, and an
average angle of 21.3°. There was significant variability in all
parameters, indicating that HIV cores are not homogeneous. Immunoblot
analysis of core preparations allowed semiquantitative estimation of
the relative amounts of viral and cellular proteins inside the HIV-1 core, yielding a model for the topology of various proteins inside the virion.
 |
INTRODUCTION |
Retroviruses contain a RNA genome
that is reverse transcribed and integrated into the host cell genome in
the early phase of infection, before viral proteins are expressed. This
mode of replication requires the presence of all necessary components of the replication and integration complexes either within the infecting virion or in the target cell. In contrast to many other enveloped viruses, retrovirus entry does not require a pH-dependent step (25), and removal of the membrane may suffice to
trigger uncoating of the genome. It appears likely, therefore, that
retroviruses contain a metastable internal structure which is stable in
the enveloped virion but readily disintegrates upon fusion of the viral
and target cell membranes. Electron microscopic (EM) analysis revealed
an internal electron-dense structure, termed the core, which has a
characteristic morphology for various groups of retroviruses (reviewed
in references 13 and 36). This
core consists of the viral genome and replication proteins encased in a
proteinaceous shell. Human immunodeficiency virus type 1 (HIV-1) is a
typical lentivirus with a characteristic cone-shaped core, while other retroviruses have spherical or tubular cores (36). Isolation and analysis of murine and avian retroviral cores were performed about
25 years ago (3, 30, 48, 49), while lentiviral cores, with
the exception of that of equine infectious anemia virus (EIAV)
(42), appear to be unstable and are rapidly disintegrated upon membrane removal (27, 32, 62). Consequently,
purification and structural and biochemical analysis of intact HIV-1
cores has not been possible.
Some information on the molecular organization of HIV-1 can be derived
from knowledge of the assembly process. Retrovirus particles bud from
the plasma membrane and are released as immature noninfectious virus,
containing a spherical electron-dense shell underneath the membrane,
instead of the mature core (reviewed in reference
13). The immature core is stable and can be easily recovered upon delipidation of the virion (39, 43, 46, 57). Extracellular maturation of the infectious virion requires proteolytic cleavage of viral polyproteins (Gag and Gag-Pol) by the viral proteinase (PR) and leads to morphological condensation of the core
(reviewed in reference 51). This mode of assembly
allows initial formation of a stable structure which is subsequently destabilized by proteolysis, once all components are confined in the
budding virion. Proteolytic maturation, therefore, switches from the
assembly to the disassembly mode and prepares the virus for the
subsequent entry step.
The dry mass of retroviral particles consists of ca. 60% protein, ca.
2 to 3% nucleic acid (genomic RNA, tRNA, and other small RNAs), and
ca. 30% lipid (53). The main structural proteins of the
virion are derived from the Gag polyprotein, Pr55 in the case of HIV-1.
Gag alone is both necessary and sufficient for formation of
extracellular particles with immature morphology (reviewed in reference
52). The Pr55gag polyprotein
consists of the matrix (MA), capsid (CA), nucleocapsid (NC), and p6
domains as well as some small spacer peptides. In the immature virion,
Gag polyproteins arrange radially, with the N-terminal membrane-binding
MA domain closely apposed to the virion membrane and the C-terminal NC
and p6 domains pointing toward the center (10, 35, 58).
Interestingly, individual domains are separated by stretches of
extended protein chain which contain the PR cleavage sites (10,
58). Proteolysis of the Gag polyprotein occurs in a sequential
ordered manner, and individual cleavages are likely to be important for
defined steps of maturation (1, 57). In the mature virion,
the order of Gag domains is largely preserved, with MA forming a thin
layer underneath the virion membrane, CA corresponding to the core
shell, and NC being part of the internal ribonucleoprotein (RNP)
complex (14). The localization of p6, which is involved in
the late stages of virus release, is not known. The viral replication
proteins are synthesized as parts of a Gag-Pol fusion protein and are
also proteolytically released in the maturing virion (reviewed in
reference 51). PR itself is encoded on the Gag-Pol
polyprotein and appears to be activated in the budding process. In the
immature virion, the Pol-derived proteins PR, reverse transcriptase
(RT), and integrase (IN) are probably localized toward the center since
they are encoded C terminally of Gag. Following maturation, at least
the nucleic acid binding proteins RT and IN are likely to be part of
the internal core and to be retained with the genome upon target cell
entry. The viral surface and transmembrane glycoproteins gp120 and gp41 are also synthesized as polyproteins but are transported and processed via the vesicular route and are acquired by the budding virion at the
plasma membrane (25).
HIV-1 encodes a number of regulatory proteins besides the prototypic
Gag, Pol, and Env proteins, and some of these are also incorporated
into the virion (reviewed in reference 6). Most notable is Vpr, which is a major constituent of the virion and is
packaged via interaction with p6 (28, 40). In addition, a
small amount of the HIV-1 Nef protein is incorporated into HIV-1 particles and cleaved by the viral PR (38, 56). The
situation is more controversial for Vif, which was reported to be
packaged into the virion (33), while more recent data
suggest that it is mostly present in cell-derived vesicles copurifying
with HIV-1 (7). Finally, the cellular chaperone cyclophilin
A (9, 50) and the cytoskeletal protein actin (37,
58) are also packaged in substantial amounts into HIV-1 virions,
most likely by interaction with the CA and NC domains of Gag,
respectively. However, except for cellular glycoproteins incorporated
into the virion membrane (14, 34), very little is known
about the topology and function of the viral and cellular accessory
proteins in the HIV-1 virion.
Most of our current understanding of the molecular organization of
HIV-1 is derived from immuno-EM studies of complete virions (8,
14, 18, 34, 54), from biochemical fractionation of subviral
components (4, 26, 33), and by analogy with other members of
the family (reviewed in reference 52). Because of
the inherent instability of the HIV-1 core, detailed characterization of its morphology and molecular architecture has not been performed. Here, we report a new procedure for the rapid isolation of intact HIV-1
cores and the structural characterization of these core particles by
negative-stain and thin-section EM as well as biochemical analysis of
their protein composition.
 |
MATERIALS AND METHODS |
Cell culture and virus preparation.
MT-4 (21) and
C8166 (44) cells were maintained at 37°C and 5%
CO2 in RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum, penicillin (100 U/ml), streptomycin (100 µg/ml), 4 mM glutamine, and 5 mM HEPES. Stocks of HIV-1 strain NL4-3
(2) were produced by transfection of HeLa cells. MT-4 cells
were initially infected with cell-free virus, and infected cultures
were subsequently expanded by cocultivation. Uninfected cells were
diluted to 5 × 105 cells per ml 4 h prior to
infection and added to an infected culture at a ratio of 10:1 followed
by vigorous mixing. Virus preparations for isolation of HIV-1 cores
were harvested before pronounced cytopathic effects were observed (24 to 32 h postinfection). Virus-containing supernatants were cleared
by low-speed centrifugation, filtered through 0.45-µm-pore-size
cellulose-acetate filters (Schleicher & Schuell), and analyzed for
antigen content by a CA-specific enzyme-linked immunosorbent assay.
Infectious titers were determined as 50% tissue culture infectious
dose by endpoint titration using serial 10-fold dilutions of virus on
octuplicate cultures of C8166 cells.
Isolation of HIV-1 cores.
Virus particles were concentrated
from cleared culture medium by centrifugation through a cushion of 20%
(wt/wt) sucrose in phosphate-buffered saline (PBS) at
130,000 × g for 2 h at 4°C. The pellet was
slowly resuspended in PBS (ca. 3.5 µl per ml of initial culture
volume). Subsequently, 40 µl of fresh virus suspension was mixed with
an equal volume of 200 mM NaCl-100 mM morpholinepropanesulfonic acid
(MOPS; pH 7.0), and virions were lysed for 2 min at room temperature by
adding Triton X-100 to a final concentration of 0.5%. HIV-1 cores were
recovered by centrifugation in a microcentrifuge at full speed
(13,800 × g) for 8 min at 4°C. The pellets were washed twice with 100 mM NaCl-50 mM MOPS (pH 7.0) and resuspended in 8 µl of the same buffer. Core suspensions were processed immediately for further analysis.
Preparation of HIV-1 cores was also attempted by ultracentrifugation
through a detergent cushion (57). In this case, concentrated virus was layered on top of a sucrose step gradient containing or
lacking detergent. The step gradient consisted of a layer of 2 ml of
20% (wt/vol) sucrose, a 1.5-ml layer of 15% (wt/vol) sucrose with or
without 0.5% Triton X-100, a 1.5-ml layer of 10% (wt/vol) sucrose
without detergent, and PBS. Gradients were centrifuged at
220,000 × g for 2 h at 4°C. Pellets were
resuspended in 100 mM NaCl-50 mM MOPS (pH 7.0) and processed
immediately for EM analysis.
EM.
For negative staining, 8-µl samples of HIV-1 core
suspensions were applied on Parafilm and covered with a UV-irradiated
Formvar-carbon-coated grid (mesh size, 200) for 5 min. After binding,
grids were washed four times with 100 mM NaCl-50 mM MOPS (pH 7.0) and
stained with 2% uranyl acetate for 5 min. Excess stain was soaked off
by touching the grid to a filter paper. After staining, the grid was
air dried.
For thin-section analysis of HIV-1 virions, freshly infected MT-4 cells
were drawn into cellulose tubes by capillary action (24),
and tubes were immersed overnight in fresh medium to allow in situ
virus production. The detailed procedure for analysis of virus
particles will be described elsewhere. Briefly, the capillary tubes
were washed in PBS 1 day after infection, and cells were fixed for
1 h with 2.5% glutaraldehyde in PBS. Subsequently, tubes were
washed with PBS and cells were postfixed within the tubes for 30 min
with 1% OsO4 in PBS, washed with water, stained for 30 min
with 1% uranyl acetate in water, and dehydrated in a graded series of
ethanol. Capillary tubes were embedded in ERL resin for sectioning.
Ultrathin sections were counterstained with 2% uranyl acetate and lead
citrate. For immunolabeling of ERL-embedded HIV-1 virions, antigens
were exposed by etching ultrathin sections for 5 min with 1% sodium
periodate in 0.5% acetic acid. Subsequently, sections were incubated
overnight with polyclonal antiserum against CA (dilution of 1:500) at
4°C, and immune complexes were detected with protein A conjugated to
10-nm gold particles.
Immunolabeling of isolated cores was performed by aspirating core
suspensions into cellulose tubes and fixing the cells with 2.5%
paraformaldehyde in PBS for 30 min. Tubes were washed with PBS, stained
for 30 min with 1% OsO4 in PBS, washed with water, and
embedded in ERL resin for sectioning. Ultrathin sections were blocked
with 1% bovine serum albumin in PBS, and antigens were detected as
described above. All electron micrographs were taken with a Philips
CM120 transmission electron microscope at 80 kV.
For morphometric analysis of negatively stained cores, images were
taken at an initial magnification of ×65,000 to ×125,000, and
high-resolution prints at a final magnification of ×165,000 to
×397,000-fold were digitized. Trace measurements of length, diameter,
and angle were performed on structurally well preserved cores, using
the SigmaScan software package (Jandel Scientific/SPSS Inc.).
Statistical analysis was performed with the SPSS software package or
Microsoft Excel.
Analysis of protein composition of HIV-1 virions and core
particles.
Virion or core particle extracts were separated by
polyacrylamide gel electrophoresis (PAGE) on sodium dodecyl sulfate
(SDS)-polyacrylamide gels containing 17.5 or 10% polyacrylamide and
were either stained with Coomassie blue or silver (23) or
used for immunoblot analysis. Smaller proteins were analyzed on
Tris-Tricine gels (45). For immunoblot analysis, proteins
were transferred to nitrocellulose membranes (Schleicher & Schuell) by
electroblotting and reacted with specific polyclonal antisera.
Peroxidase-conjugated anti-rabbit serum (dilution of 1:10,000; Jackson
Immunochemicals Inc.) was used as the secondary antibody, and immune
complexes were visualized by enhanced chemiluminescence (Amersham)
according to the manufacturer's instructions. In some cases, blots
were stripped and reprobed as recommended by the manufacturer. Rabbit
polyclonal antisera against MA, CA, NC, PR, IN, and Nef had been raised
in our laboratory, using purified bacterially expressed proteins.
Rabbit polyclonal antisera against p6, RT, Vpr, cyclophilin A, actin,
and gp120 were kind gifts of S. Campbell, R. Goody, U. Schubert, U. von Schwedler, G. Rutter, and V. Bosch, respectively.
 |
RESULTS |
Production of high-titered HIV-1 preparations and isolation of
viral cores.
For isolation of intact viral cores, it is important
to obtain large amounts of pure and highly infectious HIV-1 particles. Retroviruses are generally rather unstable, and the half-life of
infectious HIV-1 (strain NL4-3) in tissue culture is on the order of 4 to 6 h at 37°C (data not shown). Therefore, harvesting virus
preparations late at the time of peak antigen concentration results in
a large excess of noninfectious particles in the culture medium and a
very low infectious unit-to-particle ratio. Furthermore, HIV-1
infection leads to pronounced cytopathic effects in the later stages of
infection, causing release of cellular vesicles which tend to copurify
with virions (16, 37). For preparation of high-titered HIV-1
stocks devoid of major cellular contaminants, it would therefore appear
optimal to harvest virus from a synchronized infection of highly
productive cells at an early time point, well before cell lysis occurs.
To this end, we infected rapidly growing MT-4 cells by coculture, with
essentially all cells positive by immunofluorescence at 16 h
postinfection and peak virus production at 20 to 30 h
postinfection (data not shown). HIV-1 particles were harvested 24 to
32 h after infection, before pronounced cytopathic effects were
observed. Under these conditions, virus preparations contained at least
1 to 2 µg of CA per ml and routinely had a titer of >107
infectious units per ml (Fig. 1).
Assuming ca. 1,800 Gag molecules per virion (53), this
corresponds to a particle-to-infectious unit ratio of approximately
1,000:1. Concentrating HIV-1 particles by ultracentrifugation through a
sucrose cushion led to recovery of 40 to 60% of input CA antigen at a
similar particle-to-infectious unit ratio, leading to a final
infectious titer of at least 109 per ml (Fig. 1). Analysis
of virion preparations showed that viral Gag proteins were the major
constituents, with comparatively little contamination by cellular
proteins (Fig. 1).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Flow chart outlining the preparation of HIV-1 cores.
Concentration of particles, relative infectivity (50% tissue culture
infectious dose [TCID50]), and HIV-1 CA protein recovery
relative to the amount present in the culture medium are shown for
various steps of a representative experiment. Comparable results were
obtained in five experiments independently performed by three members
of the laboratory. The insert shows a Coomassie blue-stained gel of
concentrated virus used for core preparation. HIV-1 structural proteins
are identified on the left; positions of molecular mass standards (in
kilodaltons) are shown on the right.
|
|
When HIV-1 particles were lysed with nonionic detergents and subjected
to ultracentrifugation, no intact cone-shaped cores were observed on
negative-stain EM analysis (data not shown). Previous experiments had
indicated that CA protein is partially retained when HIV-1 is
centrifuged through a layer of detergent (57), and we
therefore analyzed the pellet fraction of sucrose step gradients
containing detergent layers for the presence of intact cores. However,
only very few cone-shaped particles which appeared damaged on
negative-stain EM were observed with a large excess of unstructured
aggregates, probably corresponding to disintegrated viruses (Fig.
2A). In our in vitro assembly
experiments, we recently observed that core-like particles tend to
aggregate and can be recovered by short centrifugation in a
microcentrifuge (20a). Assuming that this may also apply to
mature HIV-1 cores, we briefly incubated concentrated HIV-1 particles
with 0.5% Triton X-100, followed by centrifugation in the
microcentrifuge for 8 min. This procedure led to recovery of 5 to 10%
of input CA antigen and virtually complete loss of infectivity (Fig.
1), with numerous intact cone-shaped cores detected by negative-stain
EM (Fig. 2B). The residual infectivity may be due either to incomplete
virus lysis or to a very low infectivity of delipidated viral cores which might be internalized by endocytotic uptake.

View larger version (135K):
[in this window]
[in a new window]
|
FIG. 2.
EM analysis of isolated HIV-1 cores (A to D) or mature
virions (E and F). Particles were visualized either by negative
staining (A to C) or on ultrathin sections (D to F). In panel A, cores
were prepared by ultracentrifugation through a detergent cushion; in
panels B to D, cores were prepared by low-speed centrifugation
following detergent stripping. Postembedding immunolabeling of HIV-1
cores (D) and virions (E) was performed with polyclonal antiserum
against HIV-1 CA and detection with protein A coupled to 10-nm gold
particles. Size bars, 100 nm.
|
|
The yield of intact HIV-1 cores depended primarily on the virus
concentration before stripping. Virtually no CA antigen and no core
particles were recovered when 10-fold less virus was used in this
procedure. In addition, recovery of intact cores was affected by the pH
and salt concentration of the buffer, with both, low, and high salt
concentrations causing a decrease of cone-shaped particles in
negative-stain EM. Thorough resuspension of the input virus concentrate
was also important for core recovery and was best performed in PBS.
EM analysis of HIV-1 core particles.
Analysis of HIV-1 core
preparations by negative-stain EM revealed numerous ordered particles
which were mostly cone shaped and tended to form loose aggregates (Fig.
2B). The tendency to aggregate was more obvious when core preparations
were analyzed by thin-section EM (Fig. 2D and data not shown). Images
taken from negatively stained preparations at higher magnification
(Fig. 2C) indicated that most cores were intact and had a continuous wall with a diameter of 5 to 6 nm. Cores appeared to be capped on both
sides. The particles closely resembled the internal structure of mature
infectious HIV-1 virions as observed by thin-section EM (Fig. 2F).
Isolated cores as well as the inner capsid structure of the virion
could be labeled in immuno-EM with antiserum against CA (Fig. 2D and
E), while no reactivity of these structures with antiserum against MA
was detected (data not shown). Besides intact cores, we also observed
damaged spherical structures and unstructured aggregates in core
preparations which may correspond to the remnants of lysed virions.
Some of these structures could be labeled in immuno-EM with antiserum
against MA (data not shown).
Thin-section EM analysis of intact HIV-1 reveals the prototypic
lentiviral cone-shaped core (Fig. 2F), but the appearance of this
structure varies depending on the plane of section (reviewed in
reference 13). Negative-stain EM analysis of
isolated intact cores, on the other hand, produces a projection of the
three-dimensional structure into a photographic plane and should
therefore allow a more thorough determination of core geometry,
provided the cores are not collapsed. In stereoscopic image pairs of
negatively stained cores tilted by ±6° in the 0° plane, cores
projected from the grid into different directions and were clearly
visible as three-dimensional objects without any apparent compression
(Fig. 3). Image pairs tilted in the 30°
plane yielded a similar result (data not shown), providing further
evidence that the three-dimensional architecture of the cores was
preserved during preparation. In addition, the walls of core particles
exhibited a regular pattern similar to that observed for in
vitro-assembled cylindrical particles derived from HIV-1 CA protein
(20). Most core particles contained internal structures of
higher density which localized toward the basis of the core and most
likely correspond to the internal ribonucleoprotein complex (Fig. 2 to
4).

View larger version (154K):
[in this window]
[in a new window]
|
FIG. 4.
Gallery of isolated HIV-1 cores. Typical examples of
negatively stained cores selected from four independent preparations
are shown at the same magnification. The size bar is indicated in panel
M.
|
|
Analysis of several hundred isolated HIV-1 cores revealed considerable
heterogeneity in size and shape. Most particles exhibited a cone-shaped
morphology, but cylindrical (Fig. 4I) and aberrantly shaped (Fig. 4L
and M) particles were also observed. Significant differences were
particularly obvious at the base of the cone, with the majority of
particles showing a tip-like projection (Fig. 4A to D). Considering the
three-dimensional architecture of a cone-shaped structure with
rotational symmetry along a central longitudinal axis, random
absorption of core structures to the grid would be expected. If the
cone base is oblique and not perpendicular to the central axis of
rotation, the two-dimensional projection of a given core can appear (i)
more triangular (Fig. 4A), (ii) with a tip between the edge and the
center (Fig. 4B and C), or (iii) like an arrowhead where the tip
projects exactly onto the central symmetry axis (Fig. 4D). More than
70% of cores exhibited tips in an intermediate position, while the
other two cases were rarely observed, as would be expected in the case
of random adsorption. A few particles exhibited a base that appeared to
be perpendicular to the central longitudinal axis (Fig. 4E) or a round
base (Fig. 4F). We also observed variation regarding the angle at the
tip of the cone (see below), yielding roughly triangular shapes (Fig. 4A to G), bullet-shaped variants (Fig. 4H), and, at a frequency of 5 to
10%, cylindrical isoforms (Fig. 4I). Rarely cores of very aberrant
length (Fig. 4K) or morphology (Fig. 4L and M) were observed.
Analysis of HIV-1 core particle geometry.
To describe the
variation in particle size and morphology more quantitatively, we
measured defined geometric parameters for 155 negatively stained HIV-1
cores. Morphometric analysis of overall length and diameter and of the
angle at the narrow end was performed on digitized images, using the
SigmaScan software package (Fig. 5). The
maximal particle length was measured along the central axis of
symmetry, and the maximal diameter was measured perpendicular to this
axis (Fig. 5A and B). For a graphic representation, we defined
arbitrary classes for each parameter and plotted the number of cores
found in each class. As shown in Fig. 5 and confirmed by the
Kolmogorov-Smirnov test for goodness of fit (data not shown), all three
parameters followed a Gaussian distribution and length and diameter
showed some skewing to the right.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 5.
Size and geometric variation of HIV-1 cores. Histograms
show the distribution of length (A), diameter (B), and angle at the
narrow end (C) of HIV-1 cores. Measurements were performed on digitized
images taken of 155 individual cores after negative staining. Images
were photographed in 26 microscopic fields and are derived from five
independent core preparations. Length and diameter were measured once
on each core, while the mean of three independent measurements was used
in case of the angle. For each parameter, arbitrary size classes were
defined and the number of cores found for each class was plotted. (D)
Tabulation of the results. Abbreviations: µ, mean; min., minimal
value; max., maximal value; , standard deviation; +/ 1 or +/
2 , fraction of particles within the range of 1 or 2 standard
deviations from the mean; µ2 , mean value calculated
for those particles within the range of 2 standard deviations from the
overall mean.
|
|
Particle length and diameter varied around means of 103 and 52 nm,
respectively (Fig. 5A and B; µ in Fig. 5D). The standard deviation in
both cases was approximately 10% of the respective mean (Fig. 5D,
); more than two-thirds of the particles were found within 1 standard deviation and ca. 95% were found within 2 standard deviations
from the mean (Fig. 5D, +/
1
or 2
). Measurement of the angle at
the tip of the core gave a mean of 21.3° (Fig. 5C) with a larger
degree of variation (standard deviation ca. 20% of the mean; Fig. 5D).
Again, more than two-thirds of particles and more than 95% of
particles were found within 1 and 2 standard deviations from the mean,
respectively (Fig. 5D). No significant differences were observed when
the mean was calculated only for those particles within 2 standard
deviations from the overall mean (Fig. 5D, µ2
),
indicating that the result was not biased by particles of aberrant
dimensions. Linear regression analysis of parameters revealed positive
correlations between diameter and length and between angle and diameter
and an inverse correlation between length and angle (data not shown).
Comparative protein analysis of virion and core preparations.
To determine the protein composition of HIV-1 cores, we performed a
comparative immunoblot analysis of core preparations and the virus
concentrate from which they were derived (Fig.
6). For a semiquantitative estimation of
the relative amounts of specific viral and cellular proteins, the
amount of core or virus extracts analyzed in immunoblots was normalized
for CA (Fig. 6B to H). In Fig. 6A, core (lane 1) and virus (lanes 2 and
3) extracts corresponding to 1.5 µg (lanes 1 and 3) and 0.3 µg
(lane 2) of CA, respectively, were analyzed on a silver-stained gel.
Most HIV-1 Gag, Pol, and Env proteins can be clearly identified in
these extracts. As expected, the HIV-1 surface glycoprotein gp120 (Fig.
6G) and the membrane-associated MA protein were substantially depleted
in the core preparation, with the amount of MA corresponding to <5 to
10% of that found in the virus concentrate (Fig. 6A and B). EM
analysis had shown that core preparations were not completely pure;
therefore, it is not possible, to discriminate between a small amount
of core-associated MA or a contamination with fragmented virions as
suggested by the presence of residual gp120. Pr55 and incompletely
processed Gag precursors, on the other hand, were enriched in the core
preparation (Fig. 4A to D), possibly due to a small population of
immature virions with a stable spherical shell. The nucleic acid
binding proteins NC (Fig. 6A and C), IN, and RT (Fig. 6A and E) were
also substantially enriched in the core preparation. Since the extracts loaded had been normalized for CA, this means an enrichment relative to
CA which forms the core shell.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of protein composition of HIV-1 virions and
cores obtained by brief centrifugation. Extracts from HIV-1 cores or
the concentrated virus preparation they were derived from were
separated by SDS-PAGE and analyzed by silver staining (A) or
immunoblotting (B to H). In panel A, the amount of extract loaded in
lanes 1 (cores) and 3 (virus) was adjusted to ca. 1.5 µg of CA;
fivefold less virus was loaded in lane 2. Note that NC stains very
poorly with silver but was clearly detected on staining of virus
concentrate with Coomassie blue (Fig. 1). The asterisk denotes the
position of Pr55 in the core preparation. In panels B to H, core (left
lanes) and virus (right lanes) extracts were normalized for comparable
amounts of CA protein. Western blots were probed with the following
polyclonal rabbit antisera against viral and cellular proteins: (B)
cocktail of anti-MA and anti-CA; (C) anti-NC; (D) anti-p6 (extracts
were separated on regular SDS-gels [lower panel] or on Tris-Tricine
gels [upper panel] for better resolution of small proteins); (E)
cocktail of anti-RT, anti-IN, anti-Vpr, and anti-cyclophilin A (CypA);
(F) anti-PR; (G) anti-gp120; (H) cocktail of anti-Nef and anti-actin.
The additional band migrating between Nef and actin in panel H probably
corresponds to IN and has been observed previously for this antiserum
(55). Specific viral and cellular proteins are identified on
the left of each panel.
|
|
In contrast, the cellular protein cyclophilin A, which binds to CA
(Fig. 6E), and the viral p6 protein, which corresponds to the
C-terminal domain of Gag (Fig. 6D), were essentially lost during core
preparation. Loss of p6 was unexpected because the C-terminal end of
Gag would be presumed to be inside the maturing core after cleavage. In
addition, p6 is responsible for incorporating Vpr into the virion
(reviewed in reference 6), and Vpr is clearly enriched in the core preparation (Fig. 6E). A p6-reactive protein probably corresponding to NC-p6 (Fig. 6C and D) was enriched in the
core preparation, most likely due to the nucleic acid binding capacity
of the NC domain. It should be noted, however, that the p6 antiserum
used exhibits a stronger reactivity toward precursor forms (compare the
relative intensity of Gag and intermediate cleavage products in Fig.
6D), and NC-p6 is not as abundant as it appears in Fig. 6D (see NC-p6
in Fig. 6C). Unexpectedly, HIV-1 PR was substantially enriched in the
core preparation (Fig. 6F). Furthermore, the proteolytically cleaved
core fragment of Nef was also enriched in the core preparation, while
actin was clearly depleted (Fig. 6H).
 |
DISCUSSION |
We have developed a simple strategy to isolate intact mature cores
from infectious HIV-1 in quantities sufficient for structural and
biochemical analysis. So far this has not been possible for HIV-1
because of the notorious instability of its core structure after
removal of the lipid membrane. The low stability of the mature core in
the absence of the viral membrane is common to all retroviruses but
appears to be more pronounced for HIV-1 (reviewed in reference
52). Accordingly, several groups reported isolation of avian and murine retroviral cores about 25 years ago (3, 30,
48, 49), but applying the same methods to HIV-1 did not yield
sufficient intact cone-shaped cores.
Our method relies on three basic parameters: (i) use of a concentrated
virus preparation of high biological activity as starting material,
(ii) brief exposure of the virus to nonionic detergent, and (iii)
gently and rapidly collecting the cores from the medium, using their
intrinsic ability to aggregate into large complexes. The idea to
collect the cores by brief centrifugation was based on our in vitro
assembly experiments which had shown that spherical assembly products
were almost quantitatively sedimented upon brief centrifugation in the
microcentrifuge (20a). Since the g force and time
of centrifugation applied are far from sufficient for sedimentation of
single particles of this size, it is clear that the purification method
must rely on aggregation. Accordingly, thin-section EM of in
vitro-assembled spheres (20a) or of stripped cone-shaped
cores recovered by brief centrifugation showed aggregates which were
apparently dissociated in negatively stained preparations. Recovery of
in vitro assembly products was lost when assembly was performed at
protein concentrations below 300 µg per ml (M. Grättinger and
H.-G. Kräusslich, unpublished data), suggesting that there is a
critical threshold concentration for aggregation. The concentrated
HIV-1 suspension used for core preparation usually had a CA
concentration of 200 to 500 µg per ml, and approximately 10% of this
antigen was recovered in the core fraction, similar to previously
described preparation methods for other retroviruses (3, 30, 42,
48, 49). If the concentration of the HIV-1 suspension was below
100 µg of CA per ml, however, virtually no cores were recovered by
the described method.
Besides protein concentration, the recovery of core particles was also
influenced by the pH and salt concentration of the buffer and by the
time of detergent treatment, while the effects of different detergents
or variation of detergent concentrations were not analyzed in this
study. In 1972, the relative effectivities of 61 detergents for the
isolation of cores from avian myeloblastosis virus (AMV) had been
determined, indicating that nonionic detergents like Triton X-100 are
quite effective and were surpassed only by detergents of the
polyoxyethylene alcohol class (47). While this report was
under review, Kotov et al. (29) also reported isolation of
intact HIV-1 cores by density gradient centrifugation through a
detergent-containing layer. The success of this procedure appeared to
depend on a high virus concentration in the starting material and very
brief exposure to detergent as well.
The core preparations that we obtained contained numerous intact
cone-shaped particles, but cores were not pure and remnants of lysed
virions were also detected. Therefore, the results of comparative
immunoblot analysis can provide only an estimate of the relative
presence or absence of certain proteins in the core preparation; they
cannot rule out the possibility that small amounts of a specific
protein are present within the cores as has been suggested for the
HIV-1 MA protein (4, 11, 26). Trace amounts of MA and of the
viral glycoproteins were previously observed in core preparations from
AMV, feline leukemia virus, mouse mammary tumor virus, EIAV, and simian
immunodeficiency virus (SIV) that had been obtained by density gradient
fractionation (3, 42, 47-49, 62), suggesting that it may be
difficult to separate all envelope components from the retroviral core.
The localization of the main structural proteins within the HIV-1
virion has previously been studied by immuno-EM (reviewed in references
13 and 52) and the immunoblot
analysis of our core preparation yielded largely similar results. A
model of the topology of viral and cellular proteins in mature HIV-1
particles is presented in Fig. 7. CA and
NC were the main components of the cores, while MA and gp120 were
almost completely depleted. Semiquantitative comparison of the core
preparation and the virus suspension from which it was derived showed
that NC as well as the replication proteins RT and IN and the accessory
Vpr protein were significantly enriched relative to CA in the core
preparation. This result could be due to partial disintegration of the
cores causing loss of their CA protein shell and sedimentation of the internal RNP complex. Alternatively, not all of the CA protein in the
virion would be part of the core shell.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 7.
Model of HIV-1 showing the topology of individual
proteins within the mature virion. Note that the number of symbols
shown for each protein does not reflect the stoichiometry of the
respective protein in the virion. Abbreviations for retroviral proteins
(31) are given in the text. CypA, cyclophilin A.
|
|
Besides IN and RT, we also detected a significant enrichment of HIV-1
PR in the core preparation. PR is a very soluble protein and does not
bind to nucleic acid, indicating that this result reflects its true
association with the HIV-1 core. PR was also found in core preparations
of AMV and EIAV (42, 48) and may thus be a constituent of
all retroviral cores. Since some PR was detected in preintegration
complexes isolated from early HIV-1-infected cells (26), one
may speculate on a PR function in the early steps of the retroviral
life cycle (41), besides its essential role in maturation.
The accessory protein Vpr was found significantly enriched in core
preparations, supporting its postulated role in transport of the HIV-1
preintegration complex to the nucleus (4, 22, 26). Using
immuno-EM analysis, Wang et al. (54) detected Vpr primarily
underneath the membrane and not in the core of HIV-1. However, these
virions were mostly immature, and the quality of the immuno-EM images
is insufficient to determine the precise localization of the protein.
The situation is controversial for the homologous Vpx proteins of HIV-2
and SIV. Vpx from SIVmac was reported to localize primarily
outside the core (32, 62), while HIV-2 Vpx was found to
cofractionate with cores in sucrose density gradients (27).
Additional support for Vpr being a constituent of the core comes from
the observation that Vpr fusions which package heterologous proteins
into HIV-1 particles were often degraded by PR inside the virion
(59). This is not surprising, considering that both PR and
Vpr are enriched within the same virion compartment. The same may be
true for HIV-1 Nef, which is packaged into HIV-1 particles, where it is
cleaved by HIV-1 PR (38, 56). The apparent association of
the larger Nef fragment with the HIV-1 core, which was also observed by
Kotov et al. (29), may indicate that virion-associated Nef
plays a role in the early phase of infection (17, 29, 38, 55,
56). Similar to MA, the C-terminal p6 product of Gag was
completely solubilized during core preparation, suggesting that it is
not a component of the core. The corresponding p9 protein of EIAV is
also located outside the core (42). The cellular chaperone
cyclophilin A, which is packaged by interaction with the CA domain of
Gag, is depleted almost quantitatively during core preparation, which correlates with its weak affinity for CA (61) and is
consistent with its proposed localization on the outer surface of the
core shell (19). Actin, which appears to be incorporated
through the NC domain of Gag (58) was also depleted in the
cores, indicating that it is probably not a structural constituent of
the core and is unlikely to be associated with NC in the mature virion.
EM analysis of negatively stained isolated HIV-1 cores revealed that
they were not collapsed but exhibited a defined three-dimensional architecture. Both ends of the core appeared to be capped. Some cores
showed an ordered wall pattern, similar to that found for in
vitro-assembled CA-derived cylinders (20). However, a more detailed analysis of their structure will require high-resolution cryo-EM with image analysis; these experiments are currently in progress. The majority of cores were cone shaped, resembling isolated cores from HIV-2, SIV, and EIAV (5, 27, 42, 62). Cylindrical isoforms were observed at a frequency of 5 to 10%; this result supports the hypothesis that the organization of in vitro-assembled CA-derived cylinders may be similar to that of the mature core shell.
Interestingly, the diameters at the narrow and wide ends of the mature
cores were similar to the minimal and maximal diameters of CA-derived
in vitro-assembled cylinders (ca. 25 to 65 nm) (D. Thomas, T. Wilk, T. Rutten, I. Gross, H.-G. Kräusslich, and S. Fuller, unpublished
data). In vitro-assembled cylinders exhibit a helical arrangement of CA
proteins, Thomas et al., unpublished data), and it is conceivable that
CA can form helices of only a certain range of diameters. This might
suggest that the mature cone-shaped core shell corresponds to a helix
of continuously changing diameters; some support for this hypothesis
can be derived from recent cryo-EM analysis of in vitro assembly
products (Thomas et al., unpublished data).
Despite their overall similarity, a large degree of variation in size
and shape of isolated cores was observed. Size variation was not
unexpected since intact retroviruses are also not uniform and exhibit a
wide range of sizes (10, 15, 53, 60). The average diameter
of HIV-1 virions has been determined by various EM methods to be
between 120 and 160 nm (10, 14, 15). Since cryo-EM is least
likely to cause shrinkage of the virion, such data may be most
accurate. Recently, Fuller et al. (10) reported that
immature HIV-1 particles ranged in diameter from 120 to 260 nm, with a
mean of 160 nm. A similar size variation was reported for immature and
mature murine leukemia virus particles (60) and was also
found for mature HIV-1 (T. Wilk, R. Welker, H.-G. Kräusslich, and
S. Fuller, unpublished data). Using a precise determination of the mass
of Rous sarcoma virus by scanning transmission EM, Vogt and Simon
recently showed a wide variation, with one- to two-thirds of the
virions deviating from the mean by more than 10% (53).
These differences are probably due to variable numbers of Gag molecules
used to assemble the immature virion, suggesting that retroviruses
tolerate remarkable variations in their assembly process. It appears
likely that the observed variation in core length and width reflects
the differences in size of the respective immature virions. Since the
negative staining technique leads to loss of water and shrinking of the
structures, it is likely that the true values for length and diameter
are somewhat higher than the reported values of 103 and 52 nm,
respectively. A higher degree of variability was observed for the angle
at the narrow end of the cone, with a standard deviation of 20%. This
higher variability may be partly due to measurement error but also
reflects the true geometric variability, as is evident when one
inspects the gallery of cores in Fig. 4. The mean angle of 21.3° is
slightly different from the 19° angle recently reported for in
vitro-assembled structures (12). The significant variation
in angles at the narrow end of isolated cores which exhibited a
Gaussian distribution between 11° and 32° in addition to the fact
that cylindrical and bullet-shaped isoforms were detected suggests a
significant degree of freedom in capsid assembly. However, all
retroviral preparations contain a large excess of noninfectious
particles; although this may be due to various defects, it is likely
that some of the observed core structures are aberrant and therefore noninfectious.
 |
ACKNOWLEDGMENTS |
We are grateful to B. Cardel for excellent technical assistance,
I. Gross for providing the basis for this approach, R. Schwarz for help
with statistical analysis, and I. Ellhof for photography. We thank S. Fuller, D. Thomas, and T. Wilk for many important suggestions and
comments. We are also grateful to K. Wiegers for enzyme-linked
immunosorbent assay measurements, for discussion, and for critically
reading the manuscript and to G. Rutter for suggestions and discussion.
This work was supported in part by grants from the German Ministry for
Education and Research and the Deutsche Forschungsgemeinschaft to
H.-G.K.
 |
FOOTNOTES |
*
Corresponding author. Mailing address:
Heinrich-Pette-Institut für experimentelle Virologie und
Immunologie an der Universität Hamburg, Martinistr. 52, D-20251
Hamburg, Germany. Phone: 49 40 48051-241. Fax: 49 40 48051-184. E-mail:
hgk{at}hpi.uni-hamburg.de.
Present address: Department of Molecular Genetics and Microbiology,
State University of New York, Stony Brook, NY 11794-5222.
 |
REFERENCES |
| 1.
|
Accola, M. A.,
S. Hoglund, and H. G. Göttlinger.
1998.
A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
J. Virol.
72:2072-2078[Abstract/Free Full Text].
|
| 2.
|
Adachi, A.,
H. E. Gendelman,
S. Koenig,
T. Folks,
R. Willey,
A. Rabson, and M. A. Martin.
1986.
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
J. Virol.
59:284-291[Abstract/Free Full Text].
|
| 3.
|
Bolognesi, D. P.,
R. Luftig, and J. H. Shaper.
1973.
Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures.
Virology
56:549-564[CrossRef][Medline].
|
| 4.
|
Bukrinsky, M. I.,
N. Sharova,
T. L. McDonald,
T. Pushkarskaya,
W. G. Tarpley, and M. Stevenson.
1993.
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.
Proc. Natl. Acad. Sci. USA
90:6125-6129[Abstract/Free Full Text].
|
| 5.
|
Chrystie, I. L., and J. D. Almeida.
1988.
The morphology of human immunodeficiency virus (HIV) by negative staining.
J. Med. Virol.
25:281-288[Medline].
|
| 6.
|
Cohen, E. A.,
R. A. Subbramanian, and H. G. Göttlinger.
1996.
Role of auxiliary proteins in retroviral morphogenesis.
Curr. Top. Microbiol. Immunol.
214:219-235[Medline].
|
| 7.
|
Dettenhofer, M., and X. F. Yu.
1999.
Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.
J. Virol.
73:1460-1467[Abstract/Free Full Text].
|
| 8.
|
Escaig-Haye, F.,
V. Grigoriev,
I. Sharova,
V. Rudneva,
A. Buckrinskaya, and J. G. Fournier.
1992.
Ultrastructural localization of HIV-1 RNA and core proteins. Simultaneous visualization using double immunogold labelling after in situ hybridization and immunocytochemistry.
J. Submicrosc. Cytol. Pathol.
24:437-443[Medline].
|
| 9.
|
Franke, E. K.,
H. E. Yuan, and J. Luban.
1994.
Specific incorporation of cyclophilin A into HIV-1 virions.
Nature
372:359-362[CrossRef][Medline].
|
| 10.
|
Fuller, S. D.,
T. Wilk,
B. E. Gowen,
H. G. Kräusslich, and V. M. Vogt.
1997.
Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle.
Curr. Biol.
7:729-738[CrossRef][Medline].
|
| 11.
|
Gallay, P.,
S. Swingler,
C. Aiken, and D. Trono.
1995.
HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.
Cell
80:379-388[CrossRef][Medline].
|
| 12.
|
Ganser, B. K.,
S. Li,
V. Y. Klishko,
J. T. Finch, and W. I. Sundquist.
1999.
Assembly and analysis of conical models for the HIV-1 core.
Science
283:80-83[Abstract/Free Full Text].
|
| 13.
|
Gelderblom, H. R.
1991.
Assembly and morphology of HIV: potential effect of structure on viral function.
AIDS
5:617-637[Medline].
|
| 14.
|
Gelderblom, H. R.,
E. H. Hausmann,
M. Özel,
G. Pauli, and M. A. Koch.
1987.
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
Virology
156:171-176[CrossRef][Medline].
|
| 15.
|
Gentile, M.,
T. Adrian,
A. Scheidler,
M. Ewald,
F. Dianzani,
G. Pauli, and H. R. Gelderblom.
1994.
Determination of the size of HIV using adenovirus type 2 as an internal length marker.
J. Virol. Methods
48:43-52[CrossRef][Medline].
|
| 16.
|
Gluschankof, P.,
I. Mondor,
H. R. Gelderblom, and Q. J. Sattentau.
1997.
Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations.
Virology
230:125-133[CrossRef][Medline].
|
| 17.
|
Goldsmith, M. A.,
M. T. Warmerdam,
R. E. Atchison,
M. D. Miller, and W. C. Greene.
1995.
Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef.
J. Virol.
69:4112-4121[Abstract].
|
| 18.
|
Goto, T.,
K. Ikuta,
J. J. Zhang,
C. Morita,
K. Sano,
M. Komatsu,
H. Fujita,
S. Kato, and M. Nakai.
1990.
The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.
Arch. Virol.
111:87-101[CrossRef][Medline].
|
| 19.
|
Grättinger, M.,
H. Hohenberg,
D. Thomas,
T. Wilk,
B. Müller, and H. G. Kräusslich.
1999.
In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A.
Virology
257:247-260[CrossRef][Medline].
|
| 20.
|
Gross, I.,
H. Hohenberg, and H. G. Kräusslich.
1997.
In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.
Eur. J. Biochem.
249:592-600[Medline].
|
| 20a.
| Gross, I., H. Hohenberg, T. Wilk, K. Wiegers, M. Grättinger, B. Müller, S. Fuller, and H.-G.
Kräusslich. A conformational switch controlling HIV-1
morphogenesis. EMBO J., in press.
|
| 21.
|
Harada, S.,
Y. Koyanagi, and N. Yamamoto.
1985.
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
Science
229:563-566[Abstract/Free Full Text].
|
| 22.
|
Heinzinger, N. K.,
M. I. Bukinsky,
S. A. Haggerty,
A. M. Ragland,
V. Kewalramani,
M. A. Lee,
H. E. Gendelman,
L. Ratner,
M. Stevenson, and M. Emerman.
1994.
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.
Proc. Natl. Acad. Sci. USA
91:7311-7315[Abstract/Free Full Text].
|
| 23.
|
Heukeshoven, J., and R. Dernick.
1988.
Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels.
Electrophoresis
9:28-32[CrossRef][Medline].
|
| 24.
|
Hohenberg, H.,
K. Mannweiler, and M. Müller.
1994.
High-pressure freezing of cell suspensions in cellulose capillary tubes.
J. Microsc.
175:34-43[Medline].
|
| 25.
|
Hunter, E.
1997.
Viral entry and receptors, p. 71-120.
In
J. M. Coffin, S. Hughes, and H. Varmus (ed.), Retroviruses. CSHL Press, Cold Spring Harbor, N.Y.
|
| 26.
|
Karageorgos, L.,
P. Li, and C. Burrell.
1993.
Characterization of HIV replication complexes early after cell-to-cell infection.
AIDS Res. Hum. Retroviruses
9:817-823[Medline].
|
| 27.
|
Kewalramani, V. N., and M. Emerman.
1996.
Vpx association with mature core structures of HIV-2.
Virology
218:159-168[CrossRef][Medline].
|
| 28.
|
Kondo, E.,
F. Mammano,
E. A. Cohen, and H. G. Göttlinger.
1995.
The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
J Virol.
69:2759-2764[Abstract].
|
| 29.
|
Kotov, A.,
J. Zhou,
P. Flicker, and C. Aiken.
1999.
Association of Nef with the human immunodeficiency virus type 1 core.
J. Virol.
73:8824-8830[Abstract/Free Full Text].
|
| 30.
|
Lange, J.,
H. Frank,
G. Hunsmann,
V. Moennig,
R. Wollmann, and W. Schäfer.
1973.
Properties of mouse leukemia viruses. VI. The core of Friend virus; isolation and constituents.
Virology
53:457-462[CrossRef][Medline].
|
| 31.
|
Leis, J.,
D. Baltimore,
J. M. Bishop,
J. Coffin,
E. Fleissner,
S. P. Goff,
S. Oroszlan,
H. Robinson,
A. M. Skalka,
H. M. Temin, et al.
1988.
Standardized and simplified nomenclature for proteins common to all retroviruses.
J. Virol.
62:1808-1809[Abstract/Free Full Text].
|
| 32.
|
Liska, V.,
D. Spehner,
M. Mehtali,
D. Schmitt,
A. Kirn, and A. M. Aubertin.
1994.
Localization of viral protein X in simian immunodeficiency virus macaque strain and analysis of its packaging requirements.
J. Gen. Virol.
75:2955-2962[Abstract/Free Full Text].
|
| 33.
|
Liu, H.,
X. Wu,
M. Newman,
G. M. Shaw,
B. H. Hahn, and J. C. Kappes.
1995.
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
J. Virol.
69:7630-7638[Abstract].
|
| 34.
|
Meerloo, T.,
M. A. Sheikh,
A. C. Bloem,
A. de Ronde,
M. Schutten,
C. A. van Els,
P. J. Roholl,
P. Joling,
J. Goudsmit, and H. J. Schuurman.
1993.
Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study.
J. Gen. Virol.
74:129-135[Abstract/Free Full Text].
|
| 35.
|
Menendez-Arias, L.,
C. Risco,
P. Pinto da Silva, and S. Oroszlan.
1992.
Purification of immature cores of mouse mammary tumor virus and immunolocalization of protein domains.
J. Virol.
66:5615-5620[Abstract/Free Full Text].
|
| 36.
|
Nermut, M. V., and D. J. Hockley.
1996.
Comparative morphology and structural classification of retroviruses.
Curr. Top. Microbiol. Immunol.
214:1-24[Medline].
|
| 37.
|
Ott, D. E.,
L. V. Coren,
B. P. Kane,
L. K. Busch,
D. G. Johnson,
R. C. Sowder II,
E. N. Chertova,
L. O. Arthur, and L. E. Henderson.
1996.
Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.
J. Virol.
70:7734-7743[Abstract].
|
| 38.
|
Pandori, M. W.,
N. J. Fitch,
H. M. Craig,
D. D. Richman,
C. A. Spina, and J. C. Guatelli.
1996.
Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
J. Virol.
70:4283-4290[Abstract].
|
| 39.
|
Park, J., and C. D. Morrow.
1993.
Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
Virology
194:843-850[CrossRef][Medline].
|
| 40.
|
Paxton, W.,
R. I. Connor, and N. R. Landau.
1993.
Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of Gag and mutational analysis.
J. Virol.
67:7229-7237[Abstract/Free Full Text].
|
| 41.
|
Roberts, M. M.,
T. D. Copeland, and S. Oroszlan.
1991.
In situ processing of a retroviral nucleocapsid protein by the viral proteinase.
Protein Eng.
4:695-700[Abstract/Free Full Text].
|
| 42.
|
Roberts, M. M., and S. Oroszlan.
1989.
The preparation and biochemical characterization of intact capsids of equine infectious anemia virus.
Biochem. Biophys. Res. Commun.
160:486-494[CrossRef][Medline].
|
| 43.
|
Rose, J. R.,
L. M. Babe, and C. S. Craik.
1995.
Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.
J. Virol.
69:2751-2758[Abstract].
|
| 44.
|
Salahuddin, S. Z.,
P. D. Markham,
F. Wong-Staal,
G. Franchini,
V. S. Kalyanaraman, and R. C. Gallo.
1983.
Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.
Virology
129:51-64[CrossRef][Medline].
|
| 45.
|
Schagger, H., and G. von Jagow.
1987.
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.
Anal. Biochem.
166:368-379[CrossRef][Medline].
|
| 46.
|
Stewart, L.,
G. Schatz, and V. M. Vogt.
1990.
Properties of avian retrovirus particles defective in viral protease.
J. Virol.
64:5076-5092[Abstract/Free Full Text].
|
| 47.
|
Stromberg, K.
1972.
Surface-active agents for isolation of the core component of avian myeloblastosis virus.
J. Virol.
9:684-697[Abstract/Free Full Text].
|
| 48.
|
Stromberg, K.,
N. E. Hurley,
N. L. Davis,
R. R. Rueckert, and E. Fleissner.
1974.
Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis.
J. Virol.
13:513-528[Abstract/Free Full Text].
|
| 49.
|
Teramoto, Y. A.,
R. D. Cardiff, and J. K. Lund.
1977.
The structure of the mouse mammary tumor virus: isolation and characterization of the core.
Virology
77:135-148[CrossRef][Medline].
|
| 50.
|
Thali, M.,
A. Bukovsky,
E. Kondo,
B. Rosenwirth,
C. T. Walsh,
J. Sodroski, and H. G. Göttlinger.
1994.
Functional association of cyclophilin A with HIV-1 virions.
Nature
372:363-365[CrossRef][Medline].
|
| 51.
|
Vogt, V. M.
1996.
Proteolytic processing and particle maturation.
Curr. Top. Microbiol. Immunol.
214:95-131[Medline].
|
| 52.
|
Vogt, V. M.
1997.
Retroviral virions and genomes, p. 27-69.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. CSHL Press, Cold Spring Harbor, N.Y.
|
| 53.
|
Vogt, V. M., and M. N. Simon.
1999.
Mass determination of Rous sarcoma virus virions by scanning transmission electron microscopy.
J. Virol.
73:7050-7055[Abstract/Free Full Text].
|
| 54.
|
Wang, J. J.,
Y. Lu, and L. Ratner.
1994.
Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy.
J. Gen. Virol.
75:2607-2614[Abstract/Free Full Text].
|
| 55.
|
Welker, R.,
M. Harris,
B. Cardel, and H. G. Kräusslich.
1998.
Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity.
J. Virol.
72:8833-8840[Abstract/Free Full Text].
|
| 56.
|
Welker, R.,
H. Kottler,
H. R. Kalbitzer, and H. G. Kräusslich.
1996.
Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
Virology
219:228-236[CrossRef][Medline].
|
| 57.
|
Wiegers, K.,
G. Rutter,
H. Kottler,
U. Tessmer,
H. Hohenberg, and H. G. Kräusslich.
1998.
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
J. Virol.
72:2846-2854[Abstract/Free Full Text].
|
| 58.
|
Wilk, T.,
B. Gowen, and S. D. Fuller.
1999.
Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.
J. Virol.
73:1931-1940[Abstract/Free Full Text].
|
| 59.
|
Wu, X.,
H. Liu,
H. Xiao,
J. Kim,
P. Seshaiah,
G. Natsoulis,
J. D. Boeke,
B. H. Hahn, and J. C. Kappes.
1995.
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
J. Virol.
69:3389-3398[Abstract].
|
| 60.
|
Yeager, M.,
E. M. Wilson-Kubalek,
S. G. Weiner,
P. O. Brown, and A. Rein.
1998.
Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.
Proc. Natl. Acad. Sci. USA
95:7299-7304[Abstract/Free Full Text].
|
| 61.
|
Yoo, S.,
D. G. Myszka,
C. Yeh,
M. McMurray,
C. P. Hill, and W. I. Sundquist.
1997.
Molecular recognition in the HIV-1 capsid/cyclophilin A complex.
J. Mol. Biol.
269:780-795[CrossRef][Medline].
|
| 62.
|
Yu, X.,
Z. Matsuda,
Q. C. Yu,
T. H. Lee, and M. Essex.
1993.
Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions.
J. Virol.
67:4386-4390[Abstract/Free Full Text].
|
Journal of Virology, February 2000, p. 1168-1177, Vol. 74, No. 3
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Purdy, J. G., Flanagan, J. M., Ropson, I. J., Rennoll-Bankert, K. E., Craven, R. C.
(2008). Critical Role of Conserved Hydrophobic Residues within the Major Homology Region in Mature Retroviral Capsid Assembly. J. Virol.
82: 5951-5961
[Abstract]
[Full Text]
-
Coren, L. V., Thomas, J. A., Chertova, E., Sowder, R. C. II, Gagliardi, T. D., Gorelick, R. J., Ott, D. E.
(2007). Mutational Analysis of the C-Terminal Gag Cleavage Sites in Human Immunodeficiency Virus Type 1. J. Virol.
81: 10047-10054
[Abstract]
[Full Text]
-
Haim, H., Steiner, I., Panet, A.
(2007). Time Frames for Neutralization during the Human Immunodeficiency Virus Type 1 Entry Phase, as Monitored in Synchronously Infected Cell Cultures. J. Virol.
81: 3525-3534
[Abstract]
[Full Text]
-
Darnell, G. A., Schroder, W. A., Gardner, J., Harrich, D., Yu, H., Medcalf, R. L., Warrilow, D., Antalis, T. M., Sonza, S., Suhrbier, A.
(2006). SerpinB2 Is an Inducible Host Factor Involved in Enhancing HIV-1 Transcription and Replication. J. Biol. Chem.
281: 31348-31358
[Abstract]
[Full Text]
-
Roy, B. B., Hu, J., Guo, X., Russell, R. S., Guo, F., Kleiman, L., Liang, C.
(2006). Association of RNA Helicase A with Human Immunodeficiency Virus Type 1 Particles. J. Biol. Chem.
281: 12625-12635
[Abstract]
[Full Text]
-
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., Sodroski, J.
(2006). From the Cover: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5{alpha} restriction factor. Proc. Natl. Acad. Sci. USA
103: 5514-5519
[Abstract]
[Full Text]
-
Davis, M. R., Jiang, J., Zhou, J., Freed, E. O., Aiken, C.
(2006). A Mutation in the Human Immunodeficiency Virus Type 1 Gag Protein Destabilizes the Interaction of the Envelope Protein Subunits gp120 and gp41. J. Virol.
80: 2405-2417
[Abstract]
[Full Text]
-
Brugger, B., Glass, B., Haberkant, P., Leibrecht, I., Wieland, F. T., Krausslich, H.-G.
(2006). The HIV lipidome: A raft with an unusual composition. Proc. Natl. Acad. Sci. USA
103: 2641-2646
[Abstract]
[Full Text]
-
Galetto, R., Giacomoni, V., Veron, M., Negroni, M.
(2006). Dissection of a Circumscribed Recombination Hot Spot in HIV-1 after a Single Infectious Cycle. J. Biol. Chem.
281: 2711-2720
[Abstract]
[Full Text]
-
Fossen, T., Wray, V., Bruns, K., Rachmat, J., Henklein, P., Tessmer, U., Maczurek, A., Klinger, P., Schubert, U.
(2005). Solution Structure of the Human Immunodeficiency Virus Type 1 p6 Protein. J. Biol. Chem.
280: 42515-42527
[Abstract]
[Full Text]
-
Lidon-Moya, M. C., Barrera, F. N., Bueno, M., Perez-Jimenez, R., Sancho, J., Mateu, M. G., Neira, J. L.
(2005). An extensive thermodynamic characterization of the dimerization domain of the HIV-1 capsid protein. Protein Sci.
14: 2387-2404
[Abstract]
[Full Text]
-
Gurer, C., Hoglund, A., Hoglund, S., Luban, J.
(2005). ATP{gamma}S Disrupts Human Immunodeficiency Virus Type 1 Virion Core Integrity. J. Virol.
79: 5557-5567
[Abstract]
[Full Text]
-
Scholz, I., Arvidson, B., Huseby, D., Barklis,